BayMedical LLC is a leading biotechnology company based in South San Francisco, CA, specializing in the development of efficient and scalable processes for the production of natural cannabinoids and novel cannabinoid analogs. Led by a world-class team, BayMedical harnesses the power of biosynthesis and synthetic chemistry to deliver a diverse portfolio of cannabinoids for various industries, including pharmaceutical, nutraceutical, cosmetic, and animal health applications.
Through their innovative platform, BayMedical utilizes engineered yeast to convert sugar into cannabinoids, addressing the inefficiency of the Cannabis sativa plant in synthesizing these compounds. Their products range from rare, non-intoxicating cannabinoids to novel analogs, offering a wide range of potential applications in the pharmaceutical, consumer, and animal health sectors. BayMedical is a subsidiary of InMed Pharmaceuticals, a global leader in rare cannabinoid manufacturing and development.
Generated from the website